Hologic Inc. recently introduced two new second shape titanium breast biopsy markers, TriMark 2S and CeleroMark 2S, containing a unique “hourglass” shape to help clinicians mark and independently identify multiple biopsy sites in the same breast. The standard TriMark identifier is a cylinder-shaped titanium pellet. The new 2S markers are half the size of the standard TriMark and can be used in conjunction with the current family of Suros biopsy site identifiers.
Technology | September 04, 2007
Hologic Introduces Suros
Technology | Mammography | December 11, 2017
Siemens Healthineers unveiled the new Mammomat Revelation premium mammography platform at the 2017 Radiological Society...
News | Breast Imaging | October 02, 2017
Hologic Inc. announced that Steve MacMillan, the company's chairman, president and CEO, joined selected employees to...
Technology | Breast Biopsy Systems | August 31, 2017
Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging...
Feature | Breast Imaging | August 30, 2017 | Dave Fornell
August 30, 2017 — This is a list of the top breast imaging content so far for 2017.
News | Biopsy Systems | July 17, 2017
Synergy Radiology Associates Employs UroNav Fusion Biopsy System for Better Prostate Cancer Diagnosis
Radiologists from Synergy Radiology Associates (SRA) in Houston are using the power of 3-D medical imaging and...
News | Biopsy Systems | March 30, 2017
March 30, 2017 — Analogic Corp.
News | Biopsy Systems | March 23, 2017
March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroN
News | Biopsy Systems | March 16, 2017
March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#986
News | Breast Imaging | March 14, 2017
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new...
Technology | Fusion Imaging Software | January 03, 2017
MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate...